[1] [1] LI X, LU L, HOU W,et al. Epigenetics in the pathogenesis of diabetic nephropathy[J]. Acta Biochimica Et Biophysica Sinica, 2022, 54(2): 163-172.

[2] [2] BARUTTA F, BELLINI S, GRUDEN G. Mechanisms of podocyte injury and implications for diabetic nephropathy[J]. Clinical Science, 2022, 136(7): 493-520.

[3] [3] HOU Y, LIN S, QIU J,et al. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy[J]. Biochemical and Biophysical Research Communications, 2020, 521(3): 791-798.

[4] [4] ABOU DAHER A, ALKHANSA S, AZAR W S,et al. Translational aspects of the mammalian target of rapamycin complexes in diabetic nephropathy[J]. Antioxidants & Redox Signaling, 2022, 37(10/12): 802-819.

[8] [8] KRISTENSEN S L, RRTH R, JHUND P S,et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials[J]. The Lancet Diabetes & Endocrinology, 2019, 7(10): 776-785.

[9] [9] ALOMARI G, AL-TRAD B, HAMDAN S,et al. Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy[J]. Drug Delivery and Translational Research, 2020, 10(1): 216-226.

[10] [10] WU L, LIU C, CHANG D Y,et al. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy[J]. Kidney International, 2021, 100(1): 107-121.

[11] [11] METLAY J P, WATERER G W. Treatment of community-acquired pneumonia during the coronavirus disease 2019 (COVID-19) pandemic[J]. Annals of Internal Medicine, 2020, 173(4): 304-305.

[12] [12] TANG B, ZHU J, FANG S,et al. Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis[J]. Free Radical Biology and Medicine, 2021, 172: 312-329.

[15] [15] SHI H, ZHAO Y, HE T,et al. Rapamycin attenuated podocyte apoptosis via upregulation of nestin in Ang II-induced podocyte injury[J]. Molecular Biology Reports, 2022, 49(3): 2119-2128.

[17] [17] LI D, REN W, JIANG Z,et al. Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury[J]. Molecular Medicine Reports, 2018, 18(5): 4399-4409.

[18] [18] ZHOU R, YANG X, LI X,et al. Recombinant CC16 inhibits NLRP3/caspase-1-induced pyroptosis through p38 MAPK and ERK signaling pathways in the brain of a neonatal rat model with sepsis[J]. Journal of Neuroinflammation, 2019, 16(1): 239.

[20] [20] LONG C, LIN Q, MO J,et al. Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress[J]. Drug Development Research, 2022, 83(4): 1047-1056.